A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants
Clinical trial NCT04860297 · COMPLETED
Trial details
- NCT number
- NCT04860297
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-16
- Primary completion
- 2023-05-22
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.